LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. FMHR 2026, 4 (3), 3196-3217.